Published Date: 05 Apr 2023
Scientists have conducted a first-of-its-kind study in a collaboration between King Abdullah University of Science and Technology (KAUST), King Abdulaziz University, Jeddah (KAU), and King Abdulaziz University Hospital, Jeddah (KAUH).
Read Full News1.
Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants
2.
Despite Medicare Coverage, Cancer Genomic Testing Still Low
3.
A study suggests that you should disregard the "pack-years" when determining your eligibility for lung cancer screening.
4.
Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet
5.
Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.
1.
Understanding Granulosa Cell Tumors: Symptoms, Diagnosis, and Treatments"
2.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
3.
Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review
4.
Ferroptosis Signaling in Tumor Progression and Therapeutic Resistance
5.
Unveiling the Hidden Benefits of Lymphedema Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
3.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation